Skip to main content
Premium Trial:

Request an Annual Quote

StarDrop Developers Acquire Software from BioFocus DPI, Launch New Firm


Developers of the StarDrop drug-optimization software package have formed a new company called Optibrium to take over the business from BioFocus DPI, a division of Galapagos.

StarDrop, used to guide compound selection in drug discovery, was originally developed at Inpharmatica, which Galapagos acquired in 2006 and folded into its BioFocus DPI division [BioInform 12-08-06].

In a statement issued this week, Optibrium said that founders Matt Segall and Ed Champness were "responsible for the development of StarDrop from 2003 and, prior to this, research and development of related technologies since 1994."

Segall and Champness formed Optibrium, based in Cambridge, UK, earlier this year in order to acquire the StarDrop software business from BioFocus. Financial terms of the acquisition were not disclosed.

Optibrium said that it is "committed to building on the success of StarDrop by developing a next generation of tools to guide decisions and optimize the drug discovery process."

Rob Arnold of Clasemont Limited, which acted as financial adviser to Optibrium, said in a statement that “there was a will on both sides for Matt and his team to achieve independence as the best way to support StarDrop’s customers and to build for the future.”

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.